Skip to main content

Stryker Value Stock - Dividend - Research Selection

Stryker

ISIN: US8636671013 , WKN: 864952

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 85 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Dividend Champion, Contender, And Challenger Highlights: Week Of March 29

2026-03-27
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Access the full list here.

Stryker restores most manufacturing after cyberattack

2026-03-27
The medtech company has been working to restore manufacturing, ordering and shipping operations since it was hit by a cyberattack on March 11.

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

2026-03-27
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

Assessing Stryker (SYK) Valuation As Views Split Between Slight Overvaluation And Modest Undervaluation

2026-03-27
Why Stryker (SYK) Is On Investors’ Radar Today Stryker (SYK) has drawn attention after recent trading, with the stock last closing at $332.68. Short term moves include a 1 day return of 1.54% and a 7 day decline of 2.08%. See our latest analysis for Stryker. The recent 1 day share price gain contrasts with a weaker 30 day share price return of a 12.76% decline and a 1 year total shareholder return of an 8.65% decline. This suggests momentum has faded after stronger three and five year total...

Stryker says manufacturing mostly restored after cyberattack

2026-03-26
Medical device maker Stryker said on Thursday its operations were steadily improving ‌towards full capacity, after a cyberattack caused ‌widespread disruption to its business. Shares of Stryker climbed 2% after ​the company said its manufacturing capability was quickly ramping with most of its sites and critical lines restored. A cyberattack on March 11 had affected Stryker's ‌operations, hindering order ⁠processing, manufacturing and shipments.

Stratus Medical Recognized on Fortune's America's Most Innovative Companies List for 2026

2026-03-25
Stratus® Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, has been named to America's Most Innovative Companies 2026 by Fortune. This recognition is presented by Fortune and powered by Statista, a global leader for business data and market research statistics. This is the first time Stratus Medical has appeared on this prestigious list, which recognizes the Company's innovation culture.

ROMTech, the Only Privately Owned MedTech Company Named to LexisNexis' Top 100 Global Innovators for 2026

2026-03-25
ROM Technologies Inc.® (ROMTech®), creator of the PortableConnect® and a national leader in intelligent rehabilitation technology, announced today that, based on the quality and strength of its patent portfolio, it has been named to the exclusive group of LexisNexis' Top 100 Global Innovators for 2026.

Medtronic inks distribution deal for Merit Medical’s basivertebral ablation system

2026-03-25
Merit’s ViaVerte nerve ablation system for chronic lower-back pain expands Medtronic’s lineup of chronic pain treatments.

Stryker Corp. (NYSE:SYK) Demonstrates a Balanced Profile for Dividend Investors

2026-03-25
Stryker (SYK) offers a reliable, growing dividend supported by strong profitability and financial health, ideal for quality-focused income investors.

Stryker announces Annual Meeting of Shareholders

2026-03-23
Portage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 6, 2026 – 12:00 p.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. A recording of the annual meeting will also be